Propionic Acid

Propionic Acid

SCHEMBL4155437

CCC(=O)O.O=c1[nH]c2ccc(CCc3ccccc3)cc2c2cc[nH]c12

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.46
GABRA1 P14867 4/20 0.45
GABRB2 P47870 3/20 0.45
IP6K1 Q92551 1/20 0.43
IP6K3 Q96PC2 1/20 0.43
IP6K2 Q9UHH9 1/20 0.43
PARP1 P09874 1/20 0.43
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
DAO P14920 2/20 0.41
PTGES O14684 1/20 0.41
ALOX5 P09917 1/20 0.39
ADORA2B P29275 2/20 0.38
ADORA1 P30542 1/20 0.38
GABRG2 P18507 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4162421 0.86 KDM4E (0.40) PPARGGABRA1GABRB2PARP1KDM4E
Propionic Acid SCHEMBL4153840 0.84 PIM1 (0.44) GABRA1KDM4EALDH1A1MEN1MAPT
Propionic Acid SCHEMBL4171576 0.82 PIM1 (0.46) PARP1KDM4EALDH1A1MEN1MAPT
Propionic Acid SCHEMBL4153189 0.82 DAO (0.41) PPARGPARP1KDM4EALDH1A1MEN1
Propionic Acid SCHEMBL4162521 0.81 FEN1 (0.44) PARP1KDM4EALDH1A1MEN1MAPT
Propionic Acid SCHEMBL4159927 0.81 ALDH1A1 (0.40) PPARGKDM4EALDH1A1MEN1MAPT
Propionic Acid SCHEMBL4162760 0.81 KDM4E (0.45) KDM4EALDH1A1MAPTHPGDHSD17B10
Propionic Acid SCHEMBL4153028 0.81 ALDH1A1 (0.36) PARP1KDM4EALDH1A1MEN1MAPT
Propionic Acid SCHEMBL4160624 0.81 MPO (0.43) GABRA1KDM4EGABRG2GABRB3GABRA5
Propionic Acid SCHEMBL4165125 0.81 PARP1 (0.47) PARP1KDM4EALDH1A1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 PPARG 1568/4885GABRA1 3395/4885GABRB2 2245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.